EVOLENT HEALTH INC's ticker is EVH and the CUSIP is 30050B101. A total of 169 filers reported holding EVOLENT HEALTH INC in Q2 2017. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $8,034,000 | -66.4% | 1,010,599 | -46.9% | 0.02% | -66.1% |
| Q1 2019 | $23,935,000 | -53.9% | 1,902,645 | -26.8% | 0.06% | -59.9% |
| Q4 2018 | $51,871,000 | +7.2% | 2,600,042 | +52.6% | 0.15% | +37.4% |
| Q3 2018 | $48,373,000 | +95.9% | 1,703,297 | +45.2% | 0.11% | +87.7% |
| Q2 2018 | $24,695,000 | +48.7% | 1,173,174 | +0.7% | 0.06% | +50.0% |
| Q1 2018 | $16,608,000 | +15.1% | 1,165,487 | -0.7% | 0.04% | +18.8% |
| Q4 2017 | $14,433,000 | -57.8% | 1,173,387 | -38.9% | 0.03% | -57.9% |
| Q3 2017 | $34,162,000 | +24.5% | 1,919,187 | +77.3% | 0.08% | +26.7% |
| Q2 2017 | $27,433,000 | +31.8% | 1,082,187 | +16.0% | 0.06% | +36.4% |
| Q1 2017 | $20,812,000 | +469.1% | 933,287 | +277.7% | 0.04% | +450.0% |
| Q4 2016 | $3,657,000 | -65.1% | 247,087 | -42.0% | 0.01% | -63.6% |
| Q3 2016 | $10,488,000 | +215.8% | 425,987 | +146.3% | 0.02% | +214.3% |
| Q2 2016 | $3,321,000 | +81.9% | 172,987 | 0.0% | 0.01% | +133.3% |
| Q1 2016 | $1,826,000 | +15.4% | 172,987 | +32.4% | 0.00% | 0.0% |
| Q4 2015 | $1,582,000 | -30.8% | 130,687 | -8.8% | 0.00% | -25.0% |
| Q3 2015 | $2,287,000 | – | 143,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engaged Capital LLC | 7,829,692 | $216,648,000 | 26.68% |
| COURAGE CAPITAL MANAGEMENT LLC | 295,158 | $8,167,000 | 5.39% |
| 13D Management LLC | 479,228 | $13,260,000 | 5.08% |
| Voce Capital Management LLC | 344,431 | $9,530,000 | 3.39% |
| Greenhouse Funds LLLP | 1,197,098 | $33,124,000 | 3.10% |
| Rock Point Advisors, LLC | 389,079 | $10,766,000 | 3.03% |
| Granahan Investment Management | 4,998,680 | $138,313,000 | 2.85% |
| Tri Locum Partners LP | 225,097 | $6,228,000 | 2.45% |
| SECTORAL ASSET MANAGEMENT INC | 552,001 | $15,274,000 | 2.30% |
| FORMULA GROWTH LTD | 330,900 | $9,156,000 | 1.63% |